V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20212888 | 20079435 | 1.52 | 52.4 | Palliative (P) | 2017-02-11 | 2017-02-19 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100218030 |
| 20212891 | 20079436 | 1.68 | 93.5 | Palliative (P) | 2016-07-06 | 2016-07-09 | CAPECITABINE + CARBOPLATIN | 02 | N | CISPLATIN + FLUOROURACIL | 101542938 |
| 20212892 | 20079437 | 1.51 | 71.3 | Curative (C) | 2019-12-18 | 2019-12-27 | Cisplatin + Modified de Gramont | 02 | Y | CISPLATIN + FLUOROURACIL | 100192535 |
| 20212894 | 20079438 | 1.72 | 71 | Curative (C) | 2016-07-31 | 2016-08-08 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101581292 |
| 20212895 | 20079439 | 1.65 | 51.7 | Palliative (P) | 2018-08-06 | 2018-08-12 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100380158 |
| 20212896 | 20079440 | 1.58 | 72.25 | Neo-adjuvant (N) | 2017-02-26 | 2017-03-05 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100770042 |
| 20212897 | 20079441 | 1.71 | 70.5 | Adjuvant (A) | 2016-11-26 | 2016-12-15 | CAPECITABINE + CARBOPLATIN | 01 | N | CAPECITABINE + CARBOPLATIN | 100996343 |
| 20212898 | 20079442 | 1.64 | 67.3 | Palliative (P) | 2018-01-02 | 2018-01-30 | CAPECITABINE + CARBOPLATIN | N | null | CAPECITABINE + CARBOPLATIN | 101550401 |
| 20212899 | 20079443 | 1.76 | 52.2 | Palliative (P) | 2019-11-24 | 2019-12-08 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 100896536 |
| 20212901 | 20079444 | null | null | Curative (C) | 2019-04-06 | 2019-05-20 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101060486 |
| 20212902 | 20079445 | 1.57 | 64.4 | Palliative (P) | 2016-02-15 | 2016-02-15 | CISPLATIN + FLUOROURACIL + RT | N | N | CISPLATIN + FLUOROURACIL | 100466821 |
| 20212903 | 20079446 | 1.59 | 74 | Palliative (P) | 2016-12-05 | 2017-01-02 | CISPLATIN + FLUOROURACIL + RT | 02 | N | CISPLATIN + FLUOROURACIL | 101045204 |
| 20212904 | 20079447 | 1.66 | 56.6 | Neo-adjuvant (N) | 2018-03-23 | 2018-03-24 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100056695 |
| 20212907 | 20079448 | 1.66 | 74 | Curative (C) | null | 2018-01-03 | CAPECITABINE + CARBOPLATIN | N | Y | DOXORUBICIN EMBOLISATION | 101495778 |
| 20212908 | 20079449 | 1.79 | 90.1 | null | 2018-07-18 | 2018-08-02 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 100505501 |
| 20212910 | 20079450 | 1.52 | 85 | Palliative (P) | 2021-02-16 | 2021-02-19 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 100291964 |
| 20212911 | 20079451 | 0 | 0 | Palliative (P) | 2021-02-28 | 2021-03-04 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 101579108 |
| 20212912 | 20079452 | 0 | 0 | Palliative (P) | 2018-09-15 | 2018-10-12 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100809231 |
| 20212913 | 20079453 | 1.6 | 78 | Neo-adjuvant (N) | 2018-10-18 | 2018-11-03 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100836755 |
| 20212914 | 20079454 | 1.76 | 77 | Curative (C) | 2019-08-16 | 2019-08-22 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 101088743 |
| 20212915 | 20079455 | 0 | 0 | Curative (C) | 2019-08-16 | 2019-08-26 | CAPECITABINE + CARBOPLATIN | N | Y | DOXORUBICIN EMBOLISATION | 101339685 |
| 20212917 | 20079456 | 1.8 | 57.6 | Curative (C) | null | 2017-07-19 | Capecitabine (21days) + Carboplatin | 02 | N | DOXORUBICIN EMBOLISATION | 100637512 |
| 20212918 | 20079457 | 1.72 | 64 | Palliative (P) | 2018-06-18 | 2018-07-28 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100242123 |
| 20212919 | 20079458 | 1.69 | 75.4 | Neo-adjuvant (N) | 2019-04-01 | 2019-04-02 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101378336 |
| 20212920 | 20079459 | 1.58 | 73.7 | Palliative (P) | 2018-04-20 | 2018-05-05 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101227845 |
| 20212921 | 20079460 | 1.66 | 68.5 | Neo-adjuvant (N) | 2018-11-15 | 2018-11-15 | CAPECITABINE + CARBOPLATIN | N | N | CAPECITABINE + CARBOPLATIN | 100352897 |
| 20212922 | 20079461 | 0 | 92.3 | Palliative (P) | 2018-08-02 | 2018-08-09 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100307747 |
| 20212923 | 20079462 | 1.74 | 62.6 | Palliative (P) | 2016-05-31 | 2016-07-04 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100919768 |
| 20212924 | 20079463 | null | null | 03 | 2016-07-16 | 2016-10-14 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 101529103 |
| 20212925 | 20079464 | 1.68 | 0 | 03 | 2019-11-13 | 2019-11-18 | Cisplatin + Fluorouracil + RT 5day | 02 | null | CISPLATIN + FLUOROURACIL | 101259440 |
| 20212926 | 20079465 | 1.67 | 107 | Curative (C) | 2018-08-05 | 2018-09-11 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101499443 |
| 20212927 | 20079466 | 1.68 | 116 | Palliative (P) | 2017-10-12 | 2017-10-24 | Doxorubicin chemoembolisation | N | N | DOXORUBICIN EMBOLISATION | 100627317 |
| 20212928 | 20079467 | 1.66 | 71.2 | Neo-adjuvant (N) | null | 2018-03-16 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101397445 |
| 20212929 | 20079468 | 0 | 89.5 | Curative (C) | 2018-04-05 | 2018-04-25 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101277280 |
| 20212930 | 20079469 | 1.49 | 85.4 | 01 | 2019-08-15 | 2019-08-15 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101576501 |
| 20212931 | 20079470 | 1.58 | 44 | null | 2018-03-10 | 2018-03-26 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101398419 |
| 20212932 | 20079471 | 1.57 | 68.4 | Palliative (P) | 2020-04-07 | 2020-04-08 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101856748 |
| 20212933 | 20079472 | 0 | 0 | Curative (C) | 2017-02-04 | 2017-03-04 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 101342145 |
| 20212934 | 20079473 | null | 52.5 | null | 2019-07-07 | 2019-07-30 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101382423 |
| 20212936 | 20079474 | 0 | 0 | Curative (C) | 2020-07-18 | 2020-08-21 | Doxorubicin chemoembolisation | 99 | Y | DOXORUBICIN EMBOLISATION | 101286163 |
| 20212937 | 20079475 | 0 | 0 | Palliative (P) | 2018-08-13 | 2018-08-30 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 101221044 |
| 20212938 | 20079476 | null | 54 | Palliative (P) | 2017-03-19 | 2017-04-15 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100282495 |
| 20212939 | 20079477 | 1.68 | null | Curative (C) | 2016-10-15 | 2016-10-21 | Cisplatin +Fluorouracil (3 wk) | 02 | Y | CISPLATIN + FLUOROURACIL | 101334274 |
| 20212940 | 20079478 | 1.7 | 48.7 | Curative (C) | 2019-12-30 | 2020-01-11 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100403264 |
| 20212941 | 20079479 | 1.75 | 49.65 | Palliative (P) | 2018-04-02 | 2018-04-16 | CAPECITABINE + CARBOPLATIN | N | N | CAPECITABINE + CARBOPLATIN | 101338340 |
| 20212942 | 20079480 | 1.81 | 63 | Palliative (P) | 2019-01-17 | 2019-01-22 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100462331 |
| 20212943 | 20079481 | 1.6 | 78.9 | 03 | 2017-02-24 | 2017-03-15 | Trial Unspecified | 01 | Y | TRIAL UNSPECIFIED | 100245207 |
| 20212945 | 20079482 | 1.5 | 102.8 | Curative (C) | 2016-06-29 | 2016-06-29 | CAPECITABINE + CARBOPLATIN | 02 | Y | CAPECITABINE + CARBOPLATIN | 100535476 |
| 20212946 | 20079483 | 1.64 | 88.2 | null | 2016-12-03 | 2016-12-17 | Capecitabine (21days) + Carboplatin | N | null | CISPLATIN + FLUOROURACIL | 100230686 |
| 20212947 | 20079484 | 1.59 | 41.5 | Neo-adjuvant (N) | 2016-11-06 | 2016-11-08 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101593428 |